Human BKRB1 full length protein-synthetic nanodisc FLP100213
Specifications
| 10µg / 50µg / 100µg |
Alternative names:
B1BKR, B1R, BKB1R, BKR1, BRADYB1
Description:
Human BKRB1 full length protein-synthetic nanodisc
Background:
Bradykinin, a 9 aa peptide, is generated in pathophysiologic conditions such as inflammation, trauma, burns, shock, and allergy. The protein encoded by this gene belongs to the G-protein coupled receptor 1 family. Two types of G-protein coupled receptors have been found which bind bradykinin and mediate responses to these pathophysiologic conditions. The protein encoded by this gene is one of these receptors and is synthesized de novo following tissue injury. Receptor binding leads to an increase in the cytosolic calcium ion concentration, ultimately resulting in chronic and acute inflammatory responses. [provided by RefSeq, Aug 2020]
Protein families:
GPCR,Transmembrane,Druggable Genome,
Protein pathways:
GPCRDB Class A Rhodopsin-like,Peptide GPCRs,Regulation of Actin Cytoskeleton KEGG,Cancer,
Expression host:
HEK293
Target:
BKRB1
Molecular weight:
The human full length BKRB1 protein has a MW of 40.5kDa
Formulation / Reconstitution:
Lyophilized from nanodisc solubilization buffer (20 mM Tris-HCl, 150 mM NaCl, pH 8.0). Normally 5% - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Usage:
Research use only
More info:
Email info@sobekbio.com
Orders:
Email orders@sobekbio.com
